Society for Surgery of the Alimentary Tract
Back to 2006 Program and Abstracts
Esophagectomy for Adenocarcinoma in the Elderly
Christian Rizzetto, Cedric Bremner, Jeffrey A. Hagen, Steve R. DeMeester, John C. Lipham, Colleen Gaughan, Christian Peyre, Brendan Boland, Daniel Oh, Tom R. DeMeester; Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA

Introduction: An aging population and a rising incidence of esophageal adenocarcinoma have resulted in more elderly patients being evaluated for esophagectomy. This procedure is associated with significant morbidity and mortality and advanced age is often considered a relative contraindication. Our purpose was to compare clinicopathologic characteristics and outcome of esophagectomy in patients 75 years and older with younger patients. Methods: Records of 420 consecutive patients who had esophagectomy from 1992 to 2005 were reviewed. The extent of operation (en-bloc, transhiatal, staged reconstruction) performed was selected based on age and comorbid conditions. Clinical characteristics, demographic information and outcome were recorded. These were compared between patients < 75 years (n=344) and those ≥ 75 years (n=76). Results: Demographic information and symptoms at presentation were similar in the 2 groups. Comorbid conditions of hypertension and cardiac disease were more common in the older group. Neoadjuvant therapy was given more common in younger patients. Cardiac complications and deep vein thrombosis were more common in the older group. Length of ICU stay was longer in the older group, however the length of hospital stay was similar in both groups. (Table). Conclusion: Esophagectomy can be performed safely in elderly patients if the extent of operation is modified based on comorbid conditions. Elderly patients are more likely to have cardiac and vascular complications and require intensive perioperative support, but mortality and hospital stay are not different.

 

< 75 years (344 patients)

≥ 75 years (76 patients)

p

Pre-operative comorbid conditions

 

 

 

Hypertension Cardiac disease

94 (27.3%) 61 (17.7%)

37 (48.7%) 31 (40.8%)

0.0005 0.0001

Neoadjuvant therapy

76 (23%)

6 (8%)

0.002

Post-operative complications

 

 

 

Surgical complication Cardiac complication Deep venous thrombosis

122 (35.5%) 46 (13.4%) 8 (2.3%)

26 (34.2%) 17 (22.3%) 7 (9.2%)

n.s. 0.052 0.009

Hospital mortality

21 (6.1%)

4 (5.2%)

n.s.

Length of ICU stay

4 days (IQR 3-7)

4 days (IQR 4-9)

n.s.

Length of hospital stay

16 days (IQR 12-23)

16 days (IQR 12-25)

0.02


Back to 2006 Program and Abstracts

Society for Surgery of the Alimentary Tract
Facebook X LinkedIn YouTube Instagram

Contact

Location 500 Cummings Center
Suite 4400
Beverly, MA 01915, USA
Phone +1 978-927-8330
Fax +1 978-524-0498